143 related articles for article (PubMed ID: 7549088)
1. Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs.
Tanaka T; Tokumura A; Tsukatani H
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1389-93. PubMed ID: 7549088
[TBL] [Abstract][Full Text] [Related]
2. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
[TBL] [Abstract][Full Text] [Related]
4. Formation of platelet-activating factor-like phospholipids by Fe2+/ascorbate/EDTA-induced lipid peroxidation.
Tanaka T; Minamino H; Unezaki S; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1993 Feb; 1166(2-3):264-74. PubMed ID: 8443246
[TBL] [Abstract][Full Text] [Related]
5. Formation of PAF-like compounds by peroxidation of phospholipids from bovine brain.
Tokumura A; Tanaka T; Yotsumoto T; Tsukatani H
J Lipid Mediat; 1992; 5(2):127-30. PubMed ID: 1525352
[TBL] [Abstract][Full Text] [Related]
6. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase.
Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K; Takahashi Y; Yamamoto S
J Lipid Res; 2000 Jun; 41(6):953-62. PubMed ID: 10828088
[TBL] [Abstract][Full Text] [Related]
7. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
[TBL] [Abstract][Full Text] [Related]
9. Identification of sn-2-omega-hydroxycarboxylate-containing phospholipids in a lipid extract from bovine brain.
Tokumura A; Tanaka T; Yotsumoto T; Tsukatani H
Biochem Biophys Res Commun; 1991 May; 177(1):466-73. PubMed ID: 2043133
[TBL] [Abstract][Full Text] [Related]
10. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids.
Zimmerman GA; Prescott SM; McIntyre TM
J Nutr; 1995 Jun; 125(6 Suppl):1661S-1665S. PubMed ID: 7782922
[TBL] [Abstract][Full Text] [Related]
11. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
12. Bioactive phospholipid oxidation products.
Marathe GK; Harrison KA; Murphy RC; Prescott SM; Zimmerman GA; McIntyre TM
Free Radic Biol Med; 2000 Jun; 28(12):1762-70. PubMed ID: 10946218
[TBL] [Abstract][Full Text] [Related]
13. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K
Biofactors; 2000; 13(1-4):29-33. PubMed ID: 11237195
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group.
Kern H; Volk T; Knauer-Schiefer S; Mieth T; Rüstow B; Kox WJ; Schlame M
Biochim Biophys Acta; 1998 Oct; 1394(1):33-42. PubMed ID: 9767093
[TBL] [Abstract][Full Text] [Related]
17. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
18. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver.
Marathe GK; Harrison KA; Roberts LJ; Morrow JD; Murphy RC; Tjoelker LW; Prescott SM; Zimmerman GA; McIntyre TM
J Lipid Res; 2001 Apr; 42(4):587-96. PubMed ID: 11290831
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Antithrombotic Properties of Salmon (
Tsoupras A; Lordan R; Shiels K; Saha SK; Nasopoulou C; Zabetakis I
Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30669323
[TBL] [Abstract][Full Text] [Related]
20. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
Kulikov VI; Muzia GI
Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
